Features
After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark Brewer deconstruct what...
Last year, Pfizer was fined a record sum for overcharging the NHS by exploiting regulation to hike the price of its drug Epanutin by 2,600%. Dr...
We arranged the top five European countries by the levels of expenditure upon pharmaceuticals, not all are from the largest countries and there's...
As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new challenges...
With us rapidly moving into 2017, we took the chance to speak to four industry heads about their take on 2016m, featuring comment from AbbVie,...
Here at Pharmafile.com, we look back at the big mergers of the year just gone and see how things have developed for the companies involved since...
The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough for those in need of...
Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its biggest stories, according to our readers.
What will be the key industry trends in 2017? Here at Pharmafile, we look ahead to what we expect could be some of the major trends that will...
Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’...
